Amritha Varshini Hanasoge Somasundara

Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms

Maria Kleppe, Richard P. Koche, Lihua Zou et al. · Cancer Cell · 2017 · 277 citations · Full text

Hematological Malignancy, Oncogenic Activation, Malignant Blood Disorder +10

Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents

Sumeet A. Khetarpal, Katrine T. Schjoldager, Christina Christoffersen et al. · Cell Metabolism · 2016 · 127 citations · Full text

Metabolic Syndrome, Lipid Disorder, Biochemistry +11

A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels

Sumeet A. Khetarpal, Xuemei Zeng, John S. Millar et al. · Nature Medicine · 2017 · 111 citations · Full text

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition

Anna Sophia McKenney, Allison N. Lau, Amritha Varshini Hanasoge Somasundara et al. · Journal of Clinical Investigation · 2018 · 76 citations · Full text

Targeting the CALR interactome in myeloproliferative neoplasms

Elodie Pronier, Paolo Cifani, Tiffany R. Merlinsky et al. · JCI Insight · 2018 · 61 citations · Full text

Hematological Malignancy, Signal Transduction, Signaling Pathway +13